Publication: Band 3 Edmonton I, a novel mutant of the anion exchanger 1 causing spherocytosis and distal renal tubular acidosis
Issued Date
2010-03-15
Resource Type
ISSN
14708728
02646021
02646021
Other identifier(s)
2-s2.0-77951929674
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biochemical Journal. Vol.426, No.3 (2010), 379-388
Suggested Citation
Carmen Chu, Naomi Woods, Nunghathai Sawasdee, Helene Guizouarn, Bernard Pellissier, Franck Borgese, Pa Thai Yenchitsomanus, Manjula Gowrishankar, Emmanuelle Cordat Band 3 Edmonton I, a novel mutant of the anion exchanger 1 causing spherocytosis and distal renal tubular acidosis. Biochemical Journal. Vol.426, No.3 (2010), 379-388. doi:10.1042/BJ20091525 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/28757
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Band 3 Edmonton I, a novel mutant of the anion exchanger 1 causing spherocytosis and distal renal tubular acidosis
Other Contributor(s)
Abstract
dRTA (distal renal tubular acidosis) and HS (hereditary spherocytosis) are two diseases that can be caused by mutations in the gene encoding the AE1 (anion exchanger 1; Band 3). dRTA is characterized by defective urinary acidification, leading to metabolic acidosis, renal stones and failure to thrive. HS results in anaemia, which may require regular blood transfusions and splenectomy. Mutations in the gene encoding AE1 rarely cause both HS and dRTA. In the present paper, we describe a novel AE1 mutation, Band 3 Edmonton I, which causes dominant HS and recessive dRTA. The patient is a compound heterozygote with the new mutation C479W and the previously described mutation G701D. Red blood cells from the patient presented a reduced amount of AE1. Expression in a kidney cell line showed that kAE1 (kidney AE1) C479W is retained intracellularly. As kAE1 is a dimer, we performed co-expression studies and found that, in kidney cells, kAE1 C479W and G701D proteins traffic independently from each other despite their ability to form heterodimers. Therefore the patient carries one kAE1 mutant that is retained in the Golgi (G701D) and another kAE1 mutant (C479W) located in the endoplasmic reticulum of kidney cells, and is thus probably unable to reabsorb bicarbonate into the blood. We conclude that the C479W mutant is a novel trafficking mutant of AE1, which causes HS due to a decreased cell-surface AE1 protein and results in dRTA due to its intracellular retention in kidney. © The Authors.